NEXTHERA CAPITAL LP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2019$6,940,000
+242.9%
60,266
-39.7%
5.78%
+387.4%
Q4 2016$2,024,000
-31.1%
100,000
-31.6%
1.19%
-34.3%
Q3 2016$2,939,000146,2001.81%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2019
NameSharesValueWeighting ↓
RA Capital Management 7,387,900$1,177,557,00016.32%
Q Global Advisors, LLC 66,714$10,634,0008.85%
Ghost Tree Capital, LLC 120,000$19,127,0005.59%
Vivo Capital, LLC 760,606$121,233,0005.44%
Spyglass Capital Management LLC 1,378,887$219,781,0005.04%
Avoro Capital Advisors LLC 1,980,000$315,592,0004.96%
Eversept Partners, LP 445,203$70,960,9064.93%
Sofinnova Investments, Inc. 499,824$79,667,0004.72%
Eventide Asset Management 1,748,648$278,717,0003.68%
Baker Brothers Advisors 4,541,604$723,886,0003.18%
View complete list of ASCENDIS PHARMA A/S shareholders